Abnormal level of other drugs, medicaments and biological substances in specimens from other organs, systems and tissues. R89.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM R89.2 became effective on October 1, 2018.
The valproic acid level in the blood must be maintained within a narrow therapeutic range. If the level is too low, someone may experience a recurrence of symptoms, but, if the level is too high, someone may experience an increase in the number and severity of symptoms and side effects.
The valproic acid test is used to measure and monitor the amount of valproic acid in the blood and determine whether the drug concentration is within the therapeutic range. The prescribed dose of the drug may be adjusted up or down depending on the results of the blood test.
encounter for blood-drug test for administrative or medicolegal reasons ( ICD-10-CM Diagnosis Code Z02.83. Encounter for blood-alcohol and blood-drug test 2016 2017 2018 2019 Billable/Specific Code POA Exempt. Use Additional code for findings of alcohol or drugs in blood (R78.-) Z02.83)
Other long term (current) drug therapy Z79. 899 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z79. 899 became effective on October 1, 2021.
ICD-10 code R79. 89 for Other specified abnormal findings of blood chemistry is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
Other specified abnormal findings of blood chemistryR7989 - ICD 10 Diagnosis Code - Other specified abnormal findings of blood chemistry - Market Size, Prevalence, Incidence, Quality Outcomes, Top Hospitals & Physicians.
ICD-10 Code for Tobacco use- Z72.
ICD-10 Code for Maternal care for cesarean scar defect (isthmocele)- O34. 22- Codify by AAPC.
Other specified abnormal findings of blood chemistry R79. 89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R79. 89 became effective on October 1, 2021.
89 and R06. 03. The code description was revised for ICD-10 codes I50. 1, I63.
ICD-10-CM Diagnosis Code R97 R97.
NCD - Partial ThromboplastinTime (PTT) (190.16)
ICD-10-CM Code for Violent behavior R45. 6.
ICD-10-CM Diagnosis Code Z79 Z79.
3 Generalized idiopathic epilepsy and epileptic syndromes.
E29.1ICD-10 code E29. 1 for Testicular hypofunction is a medical classification as listed by WHO under the range - Endocrine, nutritional and metabolic diseases .
ICD-10 code D69. 6 for Thrombocytopenia, unspecified is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
Abnormal level of other drugs, medicaments and biological substances in specimens from other organs, systems and tissues 1 R89.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 Short description: Abn lev drug/meds/biol subst in specimens from oth org/tiss 3 The 2021 edition of ICD-10-CM R89.2 became effective on October 1, 2020. 4 This is the American ICD-10-CM version of R89.2 - other international versions of ICD-10 R89.2 may differ.
The 2022 edition of ICD-10-CM R89.2 became effective on October 1, 2021.
Clinical Information. (fer-e-sis) a procedure in which blood is collected, part of the blood such as platelets or white blood cells is taken out, and the rest of the blood is returned to the donor.
Any procedure in which blood is withdrawn from a donor, a portion is separated and retained and the remainder is returned to the donor.
A code also note instructs that 2 codes may be required to fully describe a condition but the sequencing of the two codes is discretionary, depending on the severity of the conditions and the reason for the encounter.
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as Z51.81. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
Categories Z40-Z53 are intended for use to indicate a reason for care. They may be used for patients who have already been treated for a disease or injury, but who are receiving aftercare or prophylactic care, or care to consolidate the treatment, or to deal with a residual state. Type 2 Excludes.
Z79.02 Long term (current) use of antithrombotics/an... Z79.1 Long term (current) use of non-steroidal anti... Z79.2 Long term (current) use of antibiotics. Z79.3 Long term (current) use of hormonal contracep... Z79.4 Long term (current) use of insulin.
The 2022 edition of ICD-10-CM Z51.81 became effective on October 1, 2021.
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code (s). The following references for the code R89.2 are found in the index:
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code R89.2 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
The therapeutic range for total valproic acid (bound and unbound) has been established at 50-125 µg/mL and 6-22 µg/mL for free valproic acid (unbound only). The recommended range for the treatment of epilepsy is 50-100 µg/mL total valproic acid, while the recommended range for the treatment of acute mania is 85-125 µg/mL total valproic acid.
If someone has a condition that results in a lower than normal amount of protein in their blood, then that person may have an excess of active "free" valproic acid. Dosages of valproic acid must be adjusted carefully until a steady concentration in the blood is reached.
Once a stable blood concentration in the therapeutic range has been achieved, the valproic acid level may then be monitored at regular intervals to ensure that it remains within the therapeutic range.
The drug is also used to treat people with recurrent migraine headaches to help prevent their occurrence and to treat certain chronic pain syndromes.
To determine the concentration of valproic acid in your blood; the purpose is to maintain a therapeutic level and monitor toxicity. When To Get Tested?
A free valproic acid test may be ordered when someone has an underlying condition that affects the balance of protein-bound drug , such as low protein level in the blood (hypoalbuminemia) or kidney or liver failure. These conditions increase the risk of having excessive amounts of valproic acid in the blood. Use of certain medications may also prompt a healthcare practitioner to order a free valproic acid test.
The test may be ordered when a person's condition does not appear to be responding to valproic acid to determine whether the concentration is too low, the medication is ineffective, and/or to determine if someone is complying with therapy (taking the valproic acid regularly).
Valproic Acid - Valproic acid is used as an anticonvulsant to treat certain types of seizures, to prevent migraine headaches and to treat various psychiatric illnesses such as bipolar disorder and aggression. Drugs that compete for protein-binding sites with valproic acid can increase the concentration of valproic acid.
This material contains content from LOINC® (http://loinc.org). The LOINC Table, LOINC Table Core are copyright © 1995-2019, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license.
Drugs that compete for protein-binding sites with valproic acid can increase the concentration of valproic acid. Therapeutic drug monitoring is useful to optimize dose. Measurement of the free concentration is useful if toxicity is suspected.